INS and metabolic dysfunction-associated steatotic liver disease: Insulin resistance (IR) is a condition whereby insulin-targeted tissues, e.g., adipose, liver, and muscle, encounter metabolic disorders, thus leading to metabolic syndrome diseases, non-alcoholic fatty liver disease (NAFLD), atherosclerosis, and T2DM [7,8,9].